Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

DOW 190-POINT PLUNGE OCT. 13 PULLS DRUG STOCKS DOWN

Executive Summary

DOW 190-POINT PLUNGE OCT. 13 PULLS DRUG STOCKS DOWN in the largest wave of selling to hit the "Street" since "Black Monday," Oct. 19, 1987. A sampling of NYSE drug stocks covered by the F-D-C Index shows declines paralleled Friday's 6.9% fall by the Dow Jones 30 Industrials, which nosedived 190.6 points, the second biggest single-day drop since the 508-point plummet nearly two years ago. Among selected drug stocks, Merck dropped 4-1/4 points (7.7%) to 72-3/4 from its Oct. 12 close; Upjohn slid 4-1/2 and 11.1% to 36; Syntex fell 3 points for the day to 43-3/8 (down 6.5%); Lilly was off 5-1/2 to 59-3/4, an 8.5% decline; Schering-Plough closed down 2-1/4 at 74, off 3% for the day; and Warner-Lambert dropped 8-1/2 points to end the week at 103-1/4, a 7.6% drop from the day before.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS016380

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel